Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Frontiers in Oncology
|
March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S Pelliccia, A Di Rocco, G Palumbo, et al.
European Journal of Gastroenterology & Hepatology
|
March 15, 2001
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group
G Saracco, A Ciancio, V Ghisetti, et al.
Hepatology (Baltimore, Md.)
|
June 30, 2001
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone
G Saracco, A Ciancio, A Olivero, et al.
Public Health
|
September 16, 2022
Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data
M Fabiani, M F Vescio, M Bressi, et al.
Oncogene
|
June 20, 2017
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A Noto, C De Vitis, M E Pisanu, et al.
Oncogene
|
April 4, 2017
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A Noto, C De Vitis, M E Pisanu, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
December 14, 2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]
F Conte, G Cappelli, F Casino, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Frontiers in Oncology
|
March 27, 2026
Correction: Siltuximab as a first-line therapy for idiopathic multicentric Castleman disease: a retrospective analysis based on the SiMuLa study of the Italian regional network
S Pelliccia, A Di Rocco, G Palumbo, et al.
European Journal of Gastroenterology & Hepatology
|
March 15, 2001
Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group
G Saracco, A Ciancio, V Ghisetti, et al.
Hepatology (Baltimore, Md.)
|
June 30, 2001
A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone
G Saracco, A Ciancio, A Olivero, et al.
Public Health
|
September 16, 2022
Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data
M Fabiani, M F Vescio, M Bressi, et al.
Oncogene
|
June 20, 2017
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A Noto, C De Vitis, M E Pisanu, et al.
Oncogene
|
April 4, 2017
Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ
A Noto, C De Vitis, M E Pisanu, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia
|
December 14, 2004
[Italian Registry of Dialysis and Transplantation: 1996-2001 experience]
F Conte, G Cappelli, F Casino, et al.
Page
of 4